NCT02308202View on ClinicalTrials.gov

DOXAZOSIN FOR PTSD

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

PTSD

Interventions

DRUG

doxazosin

DRUG

Perindopril

DRUG

Placebo

Trial Locations (1)

77030

Baylor College of Medicine, Houston

All Listed Sponsors

lead

Baylor College of Medicine

OTHER

NCT02308202 - DOXAZOSIN FOR PTSD | Biotech Hunter | Biotech Hunter